Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05685173
Title A Trial to Study if REGN5837 in Combination With Odronextamab is Safe for Participants With Aggressive B-cell Non-Hodgkin Lymphomas (ATHENA-1)
Acronym ATHENA-1
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Regeneron Pharmaceuticals
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | GBR

Facility Status City State Zip Country Details
City of Hope RECRUITING Duarte California 91010 United States Details
Norton Cancer Institute RECRUITING Louisville Kentucky 40241 United States Details
Massachusetts General Hospital RECRUITING Boston Massachusetts 02114 United States Details
Beth Israel Deaconess Medical Center (BIDMC) RECRUITING Boston Massachusetts 02215-5400 United States Details
Rutgers Cancer Institute of New Jersey RECRUITING New Brunswick New Jersey 08903 United States Details
Laura and Isaac Perlmutter Cancer Center (NYU Cancer Institute (NYUCI) RECRUITING New York New York 10016 United States Details
Icahn School of Medicine at Mount Sinai RECRUITING New York New York 10029 United States Details
University of Texas (UT) - Southwestern Medical Center RECRUITING Dallas Texas 75390 United States Details
Royal Cornwall Hospitals NHS Trust RECRUITING Truro Cornwall TR1 3LQ United Kingdom Details
The Christie NHS Foundation Trust RECRUITING Withington Manchester M20 4BQ United Kingdom Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field